Presence of Intratumoral Stem Cells in Breast Cancer Patients with or without BRCA Germline Mutations.

被引：0
|
作者：
Singer, C. F. [1 ]
Zabkova, P. [1 ]
Pfeiler, G. [1 ]
Gschwantler-kaulich, D. [1 ]
Fink-Retter, A. [1 ]
Staudigl, C. [1 ]
Walter, I [1 ]
Hudelist, G. [1 ]
Spiess, A-C [1 ]
Kubista, E. [1 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
来源：
CANCER RESEARCH | 2009年 / 69卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：588S / 588S
页数：1
相关论文
共 50 条
  • [31] Breast cancer stem cells mutations: A new understanding of intratumoral heterogeneity.
    Donovan, Cory
    Skinner, Amy
    Pommier, Rodney F.
    Alabran, Jennifer L.
    Muller, Patrick
    Gordon, Nicole
    Vetto, John T.
    Naik, Arpana
    Pommier, SuEllen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [32] BRCA2 Germline Mutations in Cypriot Patients With Familial Breast/Ovarian Cancer
    Hadjisavvas, Andreas
    Charalambous, Elpida
    Adamou, Adamos
    Christodoulou, Christina G.
    Kyriacou, Kyriacos
    HUMAN MUTATION, 2003, 21 (02)
  • [33] BRCA2 Germline Mutations in Male Breast Cancer Patients in the Polish Population
    Kwiatkowska, Eliza
    Teresiak, Marek
    Lamperska, Katarzyna M.
    Karczewska, Aldona
    Breborowicz, Danuta
    Stawicka, Malgorzata
    Godlewski, Dariusz
    Krzyzosiak, Wlodzimierz J.
    Mackiewicz, Andrzej
    HUMAN MUTATION, 2001, 17 (01)
  • [34] Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients
    Verhoog, LC
    Berns, EMJJ
    Brekelmans, CTM
    Seynaeve, C
    Meijers-Heijboer, EJ
    Klijn, JGM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 119S - 124S
  • [35] BRCA1 germline mutations in Chinese patients with hereditary breast and ovarian cancer
    Li, N
    Zhang, X
    Cai, Y
    Xu, X
    Zhang, L
    Pan, KF
    Wu, LY
    Wang, MR
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 172 - 178
  • [36] BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations
    Ahn, Sei Hyun
    Son, Byung Ho
    Yoon, Kyung-Sik
    Noh, Dong-Young
    Han, Wonshik
    Kim, Sung-Won
    Lee, Eun Sook
    Park, Hai-Lin
    Hong, Young Joon
    Choi, Jae Jin
    Moon, Seo Yun
    Kim, Mi Jeong
    Kim, Kye Hyun
    Kwak, Beom Seok
    Cho, Dae-Yeon
    CANCER LETTERS, 2007, 245 (1-2) : 90 - 95
  • [37] PROREPAIR-A: Clinical and molecular characterization study of prostate cancer (PC) patients with and without previously known germline BRCA1/2 mutations.
    Lozano, Rebeca
    Castro, Elena
    Aragon, Isabel
    Thorne, Heather
    Lopez-Campos, Fernando
    Sanz, Alejandro
    Alonso, Concepcion
    Anido, Urbano
    Maria Jose, Juan
    Gutierrez Pecharroman, Ana
    Ramirez-Backhaus, Miguel
    Balmana Gelpi, Judith
    Chirivella, Isabel
    Llort, Gemma
    Romero-Laorden, Nuria
    Arevalo, Sara
    Rubio, Jose
    Di Domenico, Tomas
    Kaur Sandhu, Shahneen
    Olmos, David
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Should the Presence of Germline BRCA1/2 Mutations Influence Treatment Selection in Breast Cancer?
    Robson, Mark E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (28) : 3724 - 3726
  • [39] Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients
    Torres, D.
    Bermejo, J. Lorenzo
    Rashid, M. U.
    Briceno, I.
    Gil, F.
    Beltran, A.
    Ariza, V.
    Hamann, U.
    SCIENTIFIC REPORTS, 2017, 7
  • [40] Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients
    Aydemir, AEM
    Luleci, G
    Ozcelik, T
    Colak, T
    Schayek, H
    Akaydin, M
    Friedman, E
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 387 - 387
12345